The European Patent Office revokes an Edwards Lifesciences transcatheter aortic valve patent that has been the center of a long-running feud with Medtronic. Medtech titan Medtronic (NYSE:MDT) landed a major win against arch-rival Edwards Lifesciences (NYSE:EW) when the European Patent Office revoked an Edwards patent at the heart of a contentious infringement lawsuit. The EPO decision stymies Edwards’ efforts to keep Medtronic’s CoreValve transcatheter aortic valve implantation system off the market, but doesn’t affect Edwards’ own sales.
Help employers find you! Check out all the jobs and post your resume.
